(Q38983476)

English

miR-211 modulates gemcitabine activity through downregulation of ribonucleotide reductase and inhibits the invasive behavior of pancreatic cancer cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 September 2017

miR-211 modulates gemcitabine activity through downregulation of ribonucleotide reductase and inhibits the invasive behavior of pancreatic cancer cells (English)

1 reference

Europe PubMed Central

8 September 2017

pancreatic cancer

1 reference

based on heuristic

inferred from title

object named as

Niccola Funel

3

0 references

Elisa Giovannetti

object named as

Elisa Giovannetti

10

0 references

author name string

Mina Maftouh

1

1 reference

Europe PubMed Central

8 September 2017

Amir Avan

2

1 reference

Europe PubMed Central

8 September 2017

Adam E Frampton

4

1 reference

Europe PubMed Central

8 September 2017

Hamid Fiuji

5

1 reference

Europe PubMed Central

8 September 2017

Serena Pelliccioni

6

1 reference

Europe PubMed Central

8 September 2017

Leandro Castellano

7

1 reference

Europe PubMed Central

8 September 2017

Valentina Galla

8

1 reference

Europe PubMed Central

8 September 2017

Godefridus J Peters

9

1 reference

Europe PubMed Central

8 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2014

1 reference

Europe PubMed Central

8 September 2017

Nucleosides, Nucleotides & Nucleic Acids

1 reference

Europe PubMed Central

8 September 2017

33

1 reference

Europe PubMed Central

8 September 2017

4-6

1 reference

Europe PubMed Central

8 September 2017

384-393

1 reference

Europe PubMed Central

8 September 2017

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

Pancreatic cancer

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice.

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

Molecular targets of gemcitabine action: rationale for development of novel drugs and drug combinations

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

MicroRNAs: small RNAs with a big role in gene regulation

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

Oncomirs - microRNAs with a role in cancer

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

miR-21: a small multi-faceted RNA.

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

High-throughput microRNA (miRNAs) arrays unravel the prognostic role of MiR-211 in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

Causes and consequences of microRNA dysregulation in cancer

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

Genome-wide characterization of pancreatic adenocarcinoma patients using next generation sequencing

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

The regulation of miRNA-211 expression and its role in melanoma cell invasiveness

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

Epigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma: impli

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2014.891741

21 January 2018

Identifiers

10.1080/15257770.2014.891741

1 reference

Europe PubMed Central

8 September 2017

1 reference

Europe PubMed Central

8 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38983476&oldid=1800762664"